NCT05816434

Brief Summary

This study is being done to find out whether extending sleep for at least an hour per night, seven days a week, predicts a higher tolerance and a higher threshold for pain. This is a 21-day study. Participants will be asked to wear sleep- and heart- monitoring watches. Pressure pain and cold pain will be measured at study visits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
11 months until next milestone

Study Start

First participant enrolled

March 18, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2025

Completed
Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

1.6 years

First QC Date

March 20, 2023

Last Update Submit

January 29, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in pressure pain threshold from before to after sleep extension

    Bilateral response to a clinically standard algometer at 3 different physical palpation sites. A higher pressure reading indicates a better pain response.

    Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).

  • Change in pressure pain tolerance from before to after sleep extension

    Bilateral response to a clinically standard algometer at 3 different physical palpation sites. A higher pressure reading indicates a better pain response.

    Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).

  • Change in weekly average of momentary pain self-reports from before to after sleep extension

    Intermittent pain intensity using a Visual Analog Scale (0-100, where 0 = "no pain", 100 = "worst pain imaginable in current circumstances"). Higher values indicated more pain, and a negative change indicates a decrease in pain.

    (averaged) Daily surveys during study week 1 (pre-intervention) and study week 2 (intervention)

  • Change in thermal pain threshold from before to after sleep extension

    Latency to respond to a bilateral cold pressor test (feet). A longer latency to threshold indicates better pain response.

    Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).

  • Change in thermal pain tolerance from before to after sleep extension

    Latency to respond to a bilateral cold pressor test (feet). A longer latency to tolerance indicates better pain response.

    Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).

  • Change in pain inhibition from before to after sleep extension

    Pain inhibition is measured as the difference in pressure pain threshold from before to after cold pressor procedure. A reduction in pressure pain threshold is typical after cold pressor procedure. A greater reduction in pain threshold indicates a better response of the pain inhibitory system.

    Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).

Study Arms (2)

Sleep Extension

EXPERIMENTAL

1 week of \>1 hour increased time in bed

Behavioral: Sleep extension

Control

NO INTERVENTION

Sustained sleep behavior

Interventions

Sleep extensionBEHAVIORAL

\>1 hour additional time in bed per night for 1 week.

Sleep Extension

Eligibility Criteria

Age18 Years - 24 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • to 24 (inclusive) years of age at enrollment
  • Fluent English speaker and reader
  • Willing to refrain from initiating new therapeutic interventions (e.g., medication; behavioral) designed to target sleep or pain for the duration of study participation

You may not qualify if:

  • Diagnosed with a sleep disorder
  • Diagnosed with a pain disorder
  • Has experienced a cold-related injury frostbite or has any other nerve damage to the feet
  • Has a history of injury to any of the muscular measurement sites for pain (I.e. shoulder, jaw, forearm)
  • Diagnosed with hypertension or cardiovascular disease
  • Evidence of hypertension
  • Diagnosed serious mental health disorder or substance use disorder
  • Taking any physician-directed pharmacologic intervention for sleep
  • Taking any physician-directed pharmacologic intervention for pain
  • Personal health history of traumatic brain injury
  • Pregnant
  • Current smoker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennsylvania State University

University Park, Pennsylvania, 16802, United States

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 20, 2023

First Posted

April 18, 2023

Study Start

March 18, 2024

Primary Completion

November 4, 2025

Study Completion

November 4, 2025

Last Updated

February 2, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share
Time Frame
The data will be shared within one year after the first publication related to primary outcomes.
Access Criteria
Request for data should be made in writing to the PI.

Locations